HeartSciences Future Growth
Future criteria checks 2/6
HeartSciences is forecast to grow earnings and revenue by 6.5% and 97.9% per annum respectively while EPS is expected to grow by 51.1% per annum.
Key information
6.5%
Earnings growth rate
51.1%
EPS growth rate
| Medical Equipment earnings growth | 17.4% |
| Revenue growth rate | 97.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 21 Sep 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2027 | 6 | -6 | N/A | N/A | 1 |
| 4/30/2026 | 2 | -7 | N/A | -7 | 2 |
| 4/30/2025 | 0 | -8 | N/A | -9 | 2 |
| 7/31/2024 | 0 | -7 | -7 | -7 | N/A |
| 4/30/2024 | 0 | -7 | -6 | -6 | N/A |
| 1/31/2024 | 0 | -6 | -6 | -6 | N/A |
| 10/31/2023 | 0 | -6 | -5 | -5 | N/A |
| 7/31/2023 | 0 | -6 | -5 | -5 | N/A |
| 4/30/2023 | 0 | -6 | -6 | -6 | N/A |
| 1/31/2023 | 0 | -7 | -5 | -5 | N/A |
| 10/31/2022 | 0 | -7 | -5 | -5 | N/A |
| 7/31/2022 | 0 | -6 | -5 | -5 | N/A |
| 4/30/2022 | 0 | -5 | -4 | -4 | N/A |
| 1/31/2022 | 0 | -4 | -3 | -3 | N/A |
| 4/30/2021 | 0 | -2 | -2 | -2 | N/A |
| 4/30/2020 | 0 | -4 | -4 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HSCS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: HSCS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: HSCS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: HSCS's revenue (97.9% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: HSCS's revenue (97.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HSCS's Return on Equity is forecast to be high in 3 years time